Prosecution Insights
Prosecution Insights
8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (75%) |
| No statute on record | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CRAIG, KAILA ANGELIQUE | 1 | 32.8% | +26.7% |
| DONOHUE, SEAN R | 1 | 41.5% | +21.7% |
| LOCKARD, JON MCCLELLAND | 1 | 74.5% | +27.0% |
| CUNNINGCHEN, KATHLEEN MARY | 1 | 63.8% | +59.5% |
| WELLS, LAUREN QUINLAN | 1 | 45.6% | +58.7% |
| JOHANSEN, PETER N. | 1 | 60.0% | +23.8% |
| BUTTICE, AUDREY L | 1 | 45.8% | +21.5% |
| SAMALA, JAGADISHWAR RAO | 1 | 68.0% | +56.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16627872 | TREATMENTS FOR A HEMATOLOGICAL MALIGNANCY | SAMALA, JAGADISHWAR RAO | 58d overdue |
| 17702648 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | CUNNINGCHEN, KATHLEEN MARY | 35d overdue |
| 16954105 | COMBINATION IMMUNOTHERAPY AND CHEMOTHERAPY FOR THE TREATMENT OF A HEMATOLOGICAL MALIGNANCY | WELLS, LAUREN QUINLAN | 30d overdue |
| 16755590 | ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJUNCTION WITH ACT-BASED CANCER THERAPIES | JOHANSEN, PETER N. | 30d overdue |
| 18044356 | METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJUNCTION WITH LINTUZUMAB-AC225 | DONOHUE, SEAN R | 11d overdue |
| 18146149 | HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | LOCKARD, JON MCCLELLAND | 14d |
| 16754400 | METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES | BUTTICE, AUDREY L | 33d |
| 18025849 | TROPHOBLAST GLYCOPROTEIN RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | CRAIG, KAILA ANGELIQUE | 39d |
| Art Unit | Apps |
|---|---|
| 1618 | 3 |
| 1647 | 2 |
| 1646 | 1 |
| 1622 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18025849 | TROPHOBLAST GLYCOPROTEIN RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | 39d | Pending | Mar 10, 2023 |
| 18044356 | METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJUNCTION WITH LINTUZUMAB-AC225 | DONOHUE, SEAN R | 1618 | §103 | Non-Final OA | 11d overdue | Pending | Mar 07, 2023 |
| 18146149 | HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | LOCKARD, JON MCCLELLAND | 1647 | Other | Non-Final OA | 14d | Pending | Dec 23, 2022 |
| 17702648 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | CUNNINGCHEN, KATHLEEN MARY | 1646 | Other | Non-Final OA | 35d overdue | Pending | Mar 23, 2022 |
| 16954105 | COMBINATION IMMUNOTHERAPY AND CHEMOTHERAPY FOR THE TREATMENT OF A HEMATOLOGICAL MALIGNANCY | WELLS, LAUREN QUINLAN | 1622 | §103 | Non-Final OA | 30d overdue | Pending | Jun 15, 2020 |
| 16755590 | ANTI-CD45-BASED LYMPHODEPLETION METHODS AND USES THEREOF IN CONJUNCTION WITH ACT-BASED CANCER THERAPIES | JOHANSEN, PETER N. | 1644 | §103 | Final Rejection | 30d overdue | Pending | Apr 12, 2020 |
| 16754400 | METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES | BUTTICE, AUDREY L | 1647 | §103 | Final Rejection | 33d | Pending | Apr 08, 2020 |
| 16627872 | TREATMENTS FOR A HEMATOLOGICAL MALIGNANCY | SAMALA, JAGADISHWAR RAO | 1618 | §103 | Non-Final OA | 58d overdue | Pending | Dec 31, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial